These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 36762561

  • 1. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.
    Sesa-Ashton G, Nolde JM, Muente I, Carnagarin R, Lee R, Macefield VG, Dawood T, Sata Y, Lambert EA, Lambert GW, Walton A, Kiuchi MG, Esler MD, Schlaich MP.
    Hypertension; 2023 Apr; 80(4):811-819. PubMed ID: 36762561
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL, SYMPLICITY HTN-3 Steering Committee Investigators.
    Lancet; 2022 Oct 22; 400(10361):1405-1416. PubMed ID: 36130612
    [Abstract] [Full Text] [Related]

  • 3. The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up.
    Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM.
    Blood Press; 2021 Feb 22; 30(1):41-50. PubMed ID: 33030064
    [Abstract] [Full Text] [Related]

  • 4. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    Wang L, Li C, Li Z, Li Q, Liu C, Sun X, He Q, Xia DS, Xia D, Lu C.
    J Hypertens; 2024 May 01; 42(5):801-808. PubMed ID: 38164953
    [Abstract] [Full Text] [Related]

  • 5. Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes.
    Al Ghorani H, Kulenthiran S, Lauder L, Recktenwald MJM, Dederer J, Kunz M, Götzinger F, Ewen S, Ukena C, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2024 Oct 01; 113(10):1384-1392. PubMed ID: 38451261
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of patients undergoing renal sympathetic denervation.
    Zeijen VJM, Feyz L, Nannan Panday R, Veen K, Versmissen J, Kardys I, Van Mieghem NM, Daemen J.
    Clin Res Cardiol; 2022 Nov 01; 111(11):1256-1268. PubMed ID: 35851428
    [Abstract] [Full Text] [Related]

  • 7. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M, Fischell TA, Parise H, Mahfoud F.
    Circulation; 2024 Jun 11; 149(24):1875-1884. PubMed ID: 38587557
    [Abstract] [Full Text] [Related]

  • 8. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis.
    Fernandes A, David C, Pinto FJ, Costa J, Ferreira JJ, Caldeira D.
    BMC Cardiovasc Disord; 2023 May 12; 23(1):249. PubMed ID: 37173636
    [Abstract] [Full Text] [Related]

  • 9. Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension.
    Liu S, Bian R, Qian Y, Liao H, Gao X, Zhang Y, Dong W.
    J Clin Hypertens (Greenwich); 2023 Jan 12; 25(1):71-77. PubMed ID: 36478498
    [Abstract] [Full Text] [Related]

  • 10. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
    Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, Pocock S, Tsioufis K, Konstantinidis D, Choi J, East C, Lauder L, Cohen DL, Kobayashi T, Schmid A, Lee DP, Ma A, Weil J, Agdirlioglu T, Schlaich MP, Shetty S, Devireddy CM, Lea J, Aoki J, Sharp ASP, Anderson R, Fahy M, DeBruin V, Brar S, Böhm M, SPYRAL HTN-ON MED Investigators.
    J Am Coll Cardiol; 2023 Nov 07; 82(19):1809-1823. PubMed ID: 37914510
    [Abstract] [Full Text] [Related]

  • 13. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K, Rommel KP, Lapusca R, Blazek S, Besler C, Hartung P, von Roeder M, Kresoja KP, Desch S, Thiele H, Lurz P.
    Hypertension; 2019 Aug 07; 74(2):341-348. PubMed ID: 31203726
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 15. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 09; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 16. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr 09; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 17. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 09; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 18. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium.
    Blood Press; 2015 May 09; 24(5):263-74. PubMed ID: 26194721
    [Abstract] [Full Text] [Related]

  • 19. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.
    Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M.
    Lancet; 2009 Apr 11; 373(9671):1275-81. PubMed ID: 19332353
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C, Ziakas A, Dimitriadis K, Davlouros P, Marketou M, Kasiakogias A, Thomopoulos C, Petroglou D, Tsiachris D, Doumas M, Skalidis E, Karvounis C, Alexopoulos D, Vardas P, Kallikazaros I, Stefanadis C, Papademetriou V, Tousoulis D.
    Clin Res Cardiol; 2017 May 11; 106(5):322-330. PubMed ID: 27957627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.